Harvard Business Review

JULY 8, 2016

The second will be disruptive business model innovation occasionally appearing in less-familiar sectors of the Chinese economy, powered by emerging entrepreneurs. The first will be continued displacement by ever-more-competitive Chinese companies who compete on cost. This presents Western companies with a fresh challenge.

Business Model 9

Business Model Innovation Company Apparel 9

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

JANUARY 15, 2017

In 13 out of 28 countries, business was distrusted and respondents were eager for greater business reform, including potentially more policies hostile to businesses’ license to operate. For example, 82% of respondents said that the pharmaceutical industry needs greater regulation. Related Video.

Survey 11

Survey Media Globalization Policies 11

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Risk and outcomes, as the scenario plays out, will be managed by predictive models, which are powered by machine learning algorithms that will improve their accuracy rates over time.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

NOVEMBER 10, 2017

Learning needs to be built into how power really works within organizations, organized around peer power, functional power, and hierarchical power. In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy.

Skills 10

Skills Agility Learning-by-Doing Content 10

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Examples of significant investments in low-value care services abound in the U.S. Some research estimates that 42% of Medicare beneficiaries receive some form of low-value care.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

NOVEMBER 7, 2017

When two separate firms with market power occupy successive positions in an industry value chain, both will try to earn a profit margin over their costs. When the partners depend on each other and also have bargaining power over each other, they often end up haggling over the surplus after the fact.

Health Care 8

Health Care Proposal Insurance B2B 8

Harvard Business Review

JULY 7, 2011

The problem limiting this manager's potential is often embedded in his or her power style. In my new book, Power Genes , I explore the link between a person's family history and the power style this person frequently displays on the job. Scarcity issues within the family system are at the heart of the Pleaser power style.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

JANUARY 22, 2014

The first concerns a complex transatlantic acquisition of a biotech company by a pharmaceutical company. There were major overlaps in corporate and operational management positions, but most employees would be retained. The second case involved the integration of a specialty company into a global pharmaceutical company.

Pharmaceuticals 8

Pharmaceuticals Uncertainty How To Middle Management 8

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. Organized demonstrations of support by stakeholder groups can send a powerful signal to policymakers. How can new firms overcome the regulations that protect incumbents? Consumer clubs.

Licensing 9

Licensing Proposal Retail Long-term 9

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Operating in a Global Marketplace. Eight of the CEOs pointed to the challenges of operating in a fast-paced global marketplace. As a pharmaceutical company, we obviously were part of that whole ecosystem.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JUNE 20, 2017

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

MARCH 11, 2013

That can be a powerful marketing technique if you have the market muscle to pull it off. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. Open-source software stimulates creativity and attracts attention.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

OCTOBER 26, 2017

The innovation of the Bolognese silk makers was to operate the Lucca machine with a hydraulic wheel, instead of by hand. Long before the Industrial Revolution , Bologna used this combination of hydraulic power and technology to bring silkworm farming to Europe at scale.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

MARCH 27, 2018

Apple and Google, for example, each control a popular mobile phone operating system platform (and key apps on that platform), Amazon controls the largest online merchant platform, and Facebook controls the largest social network platform. Is it OK for a few firms to possess so much data and thereby wield so much power? In the U.S.,

Company 10

Company Advertising Incentives Engineering 10

Harvard Business Review

MAY 16, 2011

They tend to play vendors off against each other and shy away from partnerships that require some sharing of power. The Sun-Netscape Alliance was formed when AOL acquired Netscape in 1998 but then sought to spin out the software operations of Netscape. Google uses a different approach to working with multiple external parties.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

OCTOBER 26, 2015

Where only the largest organizations could operate 24-hour call centers, today, even small organizations have access to companies like Global Response. Start an online store (Shopify or BigCommerce) or get your brick-and-mortar operation up and running (Square or PayPal). But it’s not necessarily a winner-takes-all scenario.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

MARCH 25, 2016

Mapping out all the steps a customer takes while interacting with your company is a powerful way to improve the experience. A few years ago, I worked with a large pharmaceutical client who wanted to improve how patients with an incurable disease self-injected their drug.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Hotels Proposal 8

Harvard Business Review

FEBRUARY 17, 2011

Nadathur's portfolio includes firms operating in drug discovery research, companion diagnostics, pharmaceutical analytics, reimbursement claims processing, patient relationship management, and specialty healthcare delivery for running clinical trials — and they all work together.

Marketing 14

Marketing Venture Capitalist Biotechnology IPO 14

Harvard Business Review

JULY 6, 2017

Through coaching, she learned to project a powerful demeanor that was genuine and compelling. The executives came from a wide array of industries, including financial services, pharmaceuticals, and media. Within a year, she achieved the promotion she sought. The average coaching engagement lasted six to 12 months.

Execution 14

Execution 360-Degree Feedback Executive Coaching Sample 14

Harvard Business Review

JUNE 3, 2016

It includes changes in how an organization interacts with its customers, citizens, or patients; in operational processes; in business models; in supply chain relationships; and in how employees use information to generate insight. Operations in a Connected World. Insight Center. Sponsored by Accenture.

Tools 8

Tools Supply Chain CRM Technology 8

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Since energy startups operate in an ecosystem dominated by incumbents, they can benefit dramatically from use of incumbent resources.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

MARCH 4, 2013

Robyn*, a close friend of mine and senior leader at a large pharmaceutical company, referred me to work with Dan, the CEO of one of her company's subsidiaries and someone she knew well. I was operating from my perspective. He was operating from his perspective. She would arrange for the three of us to meet. But Dan wasn't.

Pharmaceuticals 8

Pharmaceuticals Open-book Operations CEO 8

Harvard Business Review

FEBRUARY 4, 2013

Most of us would say it's exceptionally hard, particularly when power is concentrated in a few incumbent companies with deeply rooted vested interests. But this focused power may be a benefit, not a risk. Perhaps surprisingly, two leading examples come from pharmaceutical companies. planets-and-counting forms of capitalism?

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

MARCH 2, 2011

McKinsey teams are beavering away in places like the United Arab Emirates and the 'Stans — Turkmenistan, say, or Tajikistan — but they're as likely to be doing operations projects as pure strategy work. The most intense competition between consulting firms is for "whale" engagements.

Consultative 15

Consultative Strategy McKinsey Porter 15

Harvard Business Review

JANUARY 31, 2013

On the innovation front, the opportunities are more diverse, but equally powerful. We see advances in materials, processes, and information technology that will make possible entirely new kinds of products and can radically alter how manufacturers operate. Innovations Are Changing The Way We Design Products.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

JULY 30, 2015

After interviewing several ad agency executives and marketing leaders in a diverse group of businesses — pharmaceutical, high-tech, manufacturing, retail, sports, and others — I’ve found a few common themes that could help explain what is going on. Agencies are slow. ” 2.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

MARCH 11, 2013

That can be a powerful marketing technique if you have the market muscle to pull it off. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. Open-source software stimulates creativity and attracts attention.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

NOVEMBER 19, 2015

In both cases participants read about a new medication that boosts immune function and reduces occurrence of the common cold, ostensibly developed by a large pharmaceutical company. We found the same to be true for chemical formulas (and other research has shown that brain scans and scientific jargon operate in a similar way).

Press Release 8

Press Release Participative Pharmaceuticals Chemicals 8

Harvard Business Review

MAY 5, 2016

And alongside the country’s bad debt (some estimates say it is $40 billion ), sanctions were commonly evaded through money laundering , which discouraged foreign banks from operating locally. Some powerful Iranian institutions are highly suspicious of Western influence. This dynamic can stall important change (e.g.,

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

SEPTEMBER 26, 2011

Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. Purpose, meaning, and recognition are more powerful motivators than economic self-interest, and large external rewards can reduce intrinsic motivation. I disagree.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

MAY 15, 2013

Organizational culture is shaped by and overlaps with other cultures — especially the broader culture of the societies in which it operates. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm). In large part, culture is a product of compensation." — Alec Haverstick.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

SEPTEMBER 30, 2016

But the claims of pay transparency’s beneficial powers go far beyond remedying pay discrimination, extending to boosting an organization’s overall morale and performance. The other group consisted of production employees operating in a factory setting.

Comparison 8

Comparison Incentives Outsourcing Self-aware 8

Harvard Business Review

MARCH 5, 2015

” Try to avoid patterns of speech that Faison refers to as “power robbers.” Emily Bayliss*, vice president of operations for a pharmaceutical market intelligence firm in New Jersey, had repeatedly assumed greater responsibilities and oversight of various groups for more than a decade.

How To 8

How To Case Study Restructuring Pharmaceuticals 8

Harvard Business Review

FEBRUARY 28, 2013

Information is power.". Carl Kerrigan,* a director of operations at a large pharmaceutical company, sees office gossip as an important communication tool. Informal exchanges of information can be just as useful as formal ones and they help you connect with colleagues. "It Differentiate between useful and negative.

Reputation 8

Reputation Case Study Information CFO 8

Harvard Business Review

NOVEMBER 25, 2015

The Chief Talent Officer at UCB Pharmaceuticals told us how he recently started inviting patients to executive meetings, so the people making decisions can see how their work makes a difference. Looking at all these processes together, it’s clear that culture is the operating system of an organization. That’s high-ToMo.

Motivation 8

Motivation Company Airlines Learning-by-Doing 8